Picture EBD Group World of Partnering Opportunities 650x100px

Product › Details

TALEN® technology (Transcription Activator-Like Effector Nuclease)

	Next higher product group	nucleic acid editing technology (DNA/RNA-editing technology)
	Status	2011-02-28 sales existent
	Organisation	Cellectis Bioresearch SAS
	Group	Cellectis (Group)
	Original research	University of Halle (Martin-Luther Universität Halle-Wittenberg)

Record changed: 2023-07-10

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for TALEN® technology (Transcription Activator-Like Effector Nuclease)

[1] Cellectis S.A.. (12/28/22). "Press Release: Cellectis Secures a €40 Million Credit Facility from the European Investment Bank to Support its Research, Development and Innovation Activities". Paris....
[2] Cellectis S.A.. (2/16/21). "Press Release: Cytovia Therapeutics and Cellectis Partner to Develop TALEN Gene-Edited iPSC-Derived Natural Killer Cells". Cambridge, MA & New York, NY....
[3] Cellectis S.A.. (4/13/20). "Press Release: Cellectis Appoints Carrie Brownstein, M.D., as Chief Medical Officer". New York, NY....
[4] Cellectis S.A.. (1/12/20). "Press Release: Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement". San Carlos, CA & New York, NY....
[5] Calyxt, Inc.. (5/22/18). "Press Release: Calyxt Announces Successful Closing of $60.9 Million Public Offering". Minneapolis, MN....
[6] Calyxt, Inc.. (5/15/18). "Press Release: Bayer CropScience, LP Agrees to Settle Lawsuit Filed by Calyxt in Delaware Chancery Court". Minneapolis, MN....
[7] Cellectis S.A.. (5/7/18). "Press Release: Cellectis Reports 1st Quarter 2018 Financial Results". New York, NY....
[8] Cellectis S.A.. (5/1/18). "Press Release: Harvard’s Wyss Institute Partners with Cellectis to Recode the Human Genome". Boston, MA & New York, NY....
[9] Cellectis S.A.. (3/13/18). "Press Release: Dr. Mathieu Simon to Retire as Cellectis’ Chief Operating Officer, Elsy Boglioli Named as Successor". New York, NY....
[10] Cellectis S.A.. (3/12/18). "Press Release: Cellectis Reports 4th Quarter and Full Year 2017 Financial Results". New York, NY....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]